临床试验公共管理平台 Clinical Trial Management Public Platform

当前位置：Public Access >页面

Chinese/English

Lenvatinib Plus PD-1 Inhibitors as First-line Treatment in Patients with Initial Unresectable Biliary Tract Cancer : A Non-randomised, Open-Label, Phase II Study

Filter Options
Patient No.		Patient Name		Patient Gender
Sitting		Education		Date of enrollment	FromTo
	More Options

Patient No	Gender	Date of enrollment	Sitting	Creater	Operate
NO participants recorded。

0/0

提示：推荐使用chrome浏览器并且在宽屏显示分辨率下使用系统。

Copyright(c) (2010-2013) .All rights reserved.临床试验公共管理平台版权所有